NNOX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Nano-X Imaging Ltd. Securities Lawsuit - Contact SueWallSt
Shareholders Who Acquired NNOX Shares in November 2025 Registered Direct Offering Urged to Review Legal Options as Lawsuit Alleges Material Misrepresentations
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SueWallSt announces that a securities class action has been filed against Nano-X Imaging Ltd. (NASDAQ: NNOX).
YOU MAY BE AFFECTED IF YOU:
- Purchased NNOX stock between March 31, 2025 and April 17, 2026
- Lost money on your Nano-X investment
- Acquired shares in or traceable to the Company's November 2025 registered direct offering
Find out if you might qualify for recovery or contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt.
Nano-X's stock fell $0.695 per share, or 24.39%, closing at $2.155 on April 20, 2026, after corrective disclosures revealed a $17.5 million impairment charge and a forced restructuring of the Company's Korean manufacturing operations. Motions for lead plaintiff must be filed with the Court by August 11, 2026.
The Alleged Registration Statement Misrepresentations
Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 prohibit making untrue statements of material fact or omitting facts necessary to make statements not misleading. The action contends that when Nano-X conducted its November 2025 registered direct offering, raising $15 million in gross proceeds from a single institutional investor, the Company's public disclosures contained materially misleading representations about its manufacturing efficiency and demand trajectory.
As pleaded in the complaint, Nano-X sold 3,826,530 ordinary shares while allegedly concealing that its self-owned Korean chip manufacturing facility was poorly aligned with actual product demand, that operating expenses and cash burn were escalating unsustainably, and that a significant restructuring was foreseeable.
Alleged Offering Proceeds and Defendant Motivation
The complaint identifies the November 2025 Offering as evidence of scienter. As alleged, while disseminating materially false statements to maintain artificially inflated share prices, Nano-X reaped $15 million in gross proceeds from the offering. The action claims defendants had both the motive and opportunity to commit fraud: the offering was priced and executed at a time when management allegedly knew that production operations were misaligned with demand and that the Korean facility faced likely impairment.
- The offering closed on November 25, 2025, just days after management touted "significant progress" across "three strategic growth pillars"
- Management represented the Company was "building a leaner, more focused organization" while allegedly concealing the need for a full manufacturing restructuring
- The 2024 annual report valued property and equipment at $45.4 million, yet within months a $17.5 million impairment would be recorded against Korean facility assets
- Plaintiffs allege the offering documents failed to disclose known trends regarding manufacturing-demand misalignment, violating Item 303 of SEC Regulation S-K
IPO Due Diligence and Scienter
The securities action asserts that defendants certified SEC filings under Sarbanes-Oxley that contained no untrue statements of material fact, while allegedly knowing that Korean manufacturing operations were unsustainable. The complaint points to repeated, highly specific statements about operational efficiency on earnings calls throughout the Class Period as evidence that defendants were intimately focused on manufacturing performance and thus aware of the growing disconnect between production capacity and actual demand.
"The PSLRA provides important protections for investors harmed by alleged securities violations. When companies raise capital from investors while allegedly concealing material operational failures, the statutory framework exists to hold them accountable." -- Joseph E. Levi, Esq.
Submit your information now or contact Joseph E. Levi, Esq. at (888) SueWallSt.
WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the NNOX Lawsuit
Q: Who is eligible to join the NNOX investor lawsuit? A: Investors who purchased NNOX stock or securities between March 31, 2025 and April 17, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses, not on whether you still hold the shares.
Q: What specific misstatements does the NNOX lawsuit allege? A: The complaint alleges Nano-X made materially false or misleading statements regarding manufacturing efficiency, product demand, and operational scalability during the class period. When the true state was revealed, the stock price declined sharply.
Q: When did Nano-X allegedly mislead investors? A: The class period runs from March 31, 2025 to April 17, 2026. The alleged fraud was revealed through corrective disclosures on April 20, 2026, causing a significant stock decline.
Q: What do NNOX investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Contact SueWallSt, a brand of Levi & Korsinsky LLP, for a no-cost, no-obligation case evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible as an absent class member.
Q: What if I already sold my NNOX shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: Can I join a different law firm's lawsuit instead? A: Multiple firms often file competing complaints. The court consolidates and appoints a single lead counsel. Contacting Levi & Korsinsky before August 11, 2026 ensures your losses are considered.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
Tel: (888) SueWallSt
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
